Clinical Trials Directory

Trials / Completed

CompletedNCT03923894

the Efficacy and Safety of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity

A 8 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Chonbuk National University Hospital · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Accepted

Summary

This study was conducted to investigated the effects of daily supplementation of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity.

Detailed description

This study was a 8-week, randomized, double-blind, placebo-controlled human trial. 100 subjects were randomly divided into Blueberry Yeast Fermentation Freeze Dying Powder extract 2.07 g or placebo group. The investigated measured Natural Killer cell activity, Cytokines, Upper respiratory infection questionnaire score, etc.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBlueberry Yeast Fermentation Freeze Dying Powder ExtractBlueberry Yeast Fermentation Freeze Dying Powder Extract 2.07 g/day for 8 weeks.
DIETARY_SUPPLEMENTPlaceboPlacebo 2.07 g/day for 8 weeks.

Timeline

Start date
2019-02-14
Primary completion
2019-05-14
Completion
2019-05-14
First posted
2019-04-23
Last updated
2019-08-26

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03923894. Inclusion in this directory is not an endorsement.